Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong

Chinese University of Hong Kong210 enrolled

Overview

A randomized controlled trial to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong.

This is a single blinded randomized controlled trial aiming to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong. This trial consists of a 24-week intervention period. Eligible families will be randomly assigned to either intervention group or control group. Smoking parent(s) in intervention group will be given face-to-face counselling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of NRT and monthly phone follow-up for counselling and support. Smoking parent(s) in control group will be given standard advice and information on smoking cessation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

210

Conditions

Smoking, Tobacco

Interventions

Nicotine patchDRUG

Four weeks of nicotine patch will be provided at the first contact, which will be prescribed using the guidelines based on the subject's daily cigarette consumption. At week-4 visit, four more weeks of NRT will be provided.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Ethnic Chinese family with children aged younger than 18 years of age. * Children who are admitted to the paediatric inpatient units or attend the paediatric specialist clinic at the Prince of Wales Hospital. * Children with at least one custodial smoking parent who is living with them. * Written informed consent obtained from parents. Exclusion Criteria: * Families not residing in Hong Kong. * Children in foster care. * Children with unclear custody. * Smoking paediatric patients. * Presence of smoking household members apart from the parents. * Smoking parent who is contraindicated to use nicotine replacement therapy.

Locations (1)

Prince of Wales Hospital

Hong Kong, Hong Kong

Outcomes

Primary Outcomes

Validated successful smoking reduction rate

Urinary cotinine validated parental successful smoking reduction rate at week-24

Time frame: Week-24

Self-reported parental successful smoking reduction rate at week-24

Self-reported reduction of daily cigarette consumption by 50% or more compared with baseline

Time frame: Week-24

Secondary Outcomes

Urinary cotinine validated parental smoking cessation rate at week-24

Time frame: Week-24

Parental self-reported smoking reduction rate of cigarette consumption

Time frame: Week-24

Parental self-reported smoking cessation rate of cigarette consumption

Parental self-reported 7-day point-prevalence tobacco abstinence

Time frame: Week-24

Change in children's urinary cotinine level from baseline to week-24

Time frame: Week-24

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.